Annual Report

Overview

The report describes a substantially reduced reporting scope after the restructuring of Suzhou First Pharmaceutical, with only the Hong Kong office included in the ESG reporting area and 16 full-time employees. It reports 6.1 tCO2e of combined Scope 1 and Scope 2 GHG emissions, comprising 4.79 tCO2e of Scope 1 and 1.31 tCO2e of Scope 2. The report also records zero work-related fatalities during 2023.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: Ends 31 December 2023
Publication date: 28 March 2024
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services